InvestorsHub Logo

Ecomike

09/19/22 2:10 PM

#3763 RE: Ecomike #3760

More on $RVVTF Covid19 drug FDA EUA trial close to big Money rally

https://thedalesreport.com/psychedelics/revive-therapeutics-phase-3-trial-for-covid-officially-enters-the-regulatory-funnel/

"Revive Therapeutics Phase 3 Trial For COVID Officially Enters The Regulatory Funnel"

On Sep 15, 2022
Share

On Wednesday, Revive Therapeutics Ltd. (CNSX: RVV) (OTCMKTS: RVVTF) took another step towards a resolution of its current Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine to treat COVID-19. The company announced that pursuant to its intention to pursue new primary symptoms endpoints, it has officially filed an amended protocol to the U.S. Food & Drug Administration.

This is huge folks!!!!